載入...
PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma
INTRODUCTION: CD44 has been proposed as a prognostic marker and a stem cell marker but studies in patients with prostate cancer have yielded inconsistent results. PATIENTS AND METHODS: Patients submitted to radical prostatectomy between 2008 and 2013 at a university hospital were followed with biann...
Na minha lista:
| 發表在: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846379/ https://ncbi.nlm.nih.gov/pubmed/29682524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2061268 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|